Trending...
- Grammy award-winning Cuban-Canadian artist Alex Cuba releases his 11th studio album, "Indole"
- California: Crime is down in San Francisco, key law enforcement partnerships yield successful results
- $73.6M Pipeline, $10M Crypto Play & Legal Firepower: Why Investors Are Watching Cycurion (N A S D A Q: CYCU) Like a Hawk
SAN DIEGO, May 11, 2021 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced that Randall Kaye, Chief Medical Officer, will present at the 21st Annual Pain Therapeutics Conference. The conference takes place virtually May 10-11th. Presentations will be available for registered attendees via the conference website.
About Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. is a privately held, clinical-stage, biotechnology company focused on the treatment of neuromuscular conditions, including acute, painful muscle spasms of the back. The company was founded in 2013 and is based in San Diego. Neurana's lead development compound is tolperisone, a novel, non-opioid, non-drowsy, non-cognitive impairing treatment, which the company is developing for the large population of patients who experience muscle spasms. In May 2018, Neurana completed a $60 million Series A financing led by Sofinnova Ventures with participation from Longitude Capital, New Leaf Venture Partners and H.I.G. BioHealth Partners to fund the clinical development of tolperisone. For additional information, please visit www.neuranapharma.com.
More on The Californer
SOURCE Neurana Pharmaceuticals, Inc.
Related Links
http://www.neuranapharma.com
About Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. is a privately held, clinical-stage, biotechnology company focused on the treatment of neuromuscular conditions, including acute, painful muscle spasms of the back. The company was founded in 2013 and is based in San Diego. Neurana's lead development compound is tolperisone, a novel, non-opioid, non-drowsy, non-cognitive impairing treatment, which the company is developing for the large population of patients who experience muscle spasms. In May 2018, Neurana completed a $60 million Series A financing led by Sofinnova Ventures with participation from Longitude Capital, New Leaf Venture Partners and H.I.G. BioHealth Partners to fund the clinical development of tolperisone. For additional information, please visit www.neuranapharma.com.
More on The Californer
- Luxury Hospitality Advisors Launches Realtor Training Based on Five Star Hotel Service Training
- Swidget Launches Luminance™ to Help Schools Achieve Alyssa's Law Compliance
- Farther's Michael Lee Named One of InvestmentNews' Rising Stars of 2025
- Growing Demand for EVA Mats Signals Shift in Car Interior Market
- 4th Annual Holidays In The Village, A European Marketplace
SOURCE Neurana Pharmaceuticals, Inc.
Related Links
http://www.neuranapharma.com
Filed Under: Business
0 Comments
Latest on The Californer
- California strengthens its pipeline for good-paying jobs, providing $25 million to train more than 22,000 workers through apprenticeship programs
- Why Voting "No on Prop 50" Makes Sense
- Hollywood In Pixels Celebrates the 8th Annual Silver Pixel Awards and Announces 2025 Campaign Pixel Winners Los Angeles, CA — Oct
- While the Trump administration cuts programs to fight hate crimes, California is taking action every day
- The AI Journal Publishes Groundbreaking Article
- Physician Calls for States Nationwide to Ensure ADA Compliance in Independent Commissions
- MEDIA ADVISORY - Strengthening Children's Mental Health Across New Jersey
- Culinage Launches to Preserve Family Recipes and the Stories Behind Them
- NumberSquad Launches Year‑Round Tax Planning Package for Small Businesses and the Self‑Employed
- GlexScale launches a unified model for sustainable SaaS expansion across EMEA
- SwagHer Society Launches to Help Black Women Be Seen and Supported
- Why Hybrid Work Makes Mileage Tracking Harder
- Faces of Rap Mothers Announces Open Submissions for Upcoming Volumes
- Countrywide Rental Elevates Adger's Hygiene Standards Through Expanded Portable Restroom Solutions
- Why Philadelphia Homeowners Should Ditch Oil for Natural Gas
- BeatsToRapOn launches Verified Music Promotion Marketplace powered by AI Agents
- Who plays xs in the flash and which episodes has her? "Schway!"
- Frankie Blair Stars in "Disturbing Intentions: Good vs. Evil," Coming to Amazon Prime & Tubi Oct. 24
- Zero-Trust Architecture: NJTRX Addresses 60% of U.S. Investors' Custody Security Concerns
- White House to fire explosive artillery over major roadway in Southern California, I-5 to be temporarily shut down on Saturday due to life safety risk